P3 Health Partners关键统计数据 业务货币单位:美元 2024/Q3 名称营收比例 定额化收入3.58亿98.78% Care coordination / management fees277万0.76% Clinical fees & insurance revenue153.6万0.42% 奖励费11.2万0.03% 地区货币单位:美元 2023/FY 名称营收比例 ...
提供P3 Health Partners (PIII)主营业务数据与分析,包含历年及最新发布的主营业务收入、成本、利润。您可按季报,中报,年报查询,还可方便地比较历史数据,快速了解P3 Health Partners主营业务状况。
P3 Health Partners Inc. 2370 Corporate Circle Suite 300 Henderson, Nevada 89074 Phone1 702 910-3950 IndustryHealthcare Provision SectorHealth Care/Life Sciences Fiscal Year-end12/2024 Revenue$1.27B Net Income-$57.77M 2023 Sales Growth20.67% ...
P3 Health Partners的EV/EBITA基准 名称代码EV/EBITA Biodesix Inc NASDAQGM:BDSX -6.5x OPKO Health Inc NASDAQGS:OPK -5.0x Accolade Inc NASDAQGS:ACCD -5.0x P3 Health Partners Inc NASDAQCM:PIII -1.5x Healthcare SECTOR:HLTH.US -1.0x agilon health Inc NYSE:AGL -0.9x 泰尼特 NYSE:THC 7.4x Ad...
P3 Health Partners Inc. 2370 Corporate Circle Suite 300 Henderson, Nevada 89074 Phone 1 702 910-3950 Industry Healthcare Provision Sector Health Care/Life Sciences Fiscal Year-end 12/2024 Revenue $1.27B Net Income -$57.77M 2023 Sales Growth 20.67% Employees 400 Board of Directors...
P3 Health Partners的4年价格总回报基准 名称代码4年价格总回报 MSP Recovery Inc NASDAQCM:MSPR -100.0% Cardiff Lexington Corp OTCPK:CDIX -99.7% P3 Health Partners Inc NASDAQCM:PIII -97.9% First Choice Healthc OTCPK:FCHS -96.5% Healthcare SECTOR:HLTH.US -90.0% agilon health Inc NYSE:AGL -89.2...
Based on 3 Wall Street analysts offering 12 month price targets for P3 Health Partners in the last 3 months. The average price target is $2.38 with a high forecast of $4.50 and a low forecast of $0.25. The average price target represents a 1090.00% change from the last price of $0.20...
About P3 Health Partners (NASDAQ: PIII): P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the lives of both patients and providers. Founded and led by physicians, P3 has an expansive network of more than 2,800 affiliated...
Novo Nordisk is a global healthcare company based in Denmark with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Using the P3 system and the blueprint as your roadmap, you can take the actions needed to earn more revenue and do more good in the world, for your family, for your partners/team, and for your clients and you won't be doing it alone!